(Circulation. 2000;102:876.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Sudden Death and Cardiovascular Collapse in Children With Restrictive Cardiomyopathy
From the Department of Pediatrics (S.M.R., D.L.K., E.O.S., J.A.T., S.W.D.) (Cardiology [S.M.R., S.W.D.], Pathology [D.L.K.], and Nutrition [E.O.S.]) and Molecular and Human Genetics (J.A.T.), Texas Children’s Hospital and Baylor College of Medicine, Houston, Tex.
Correspondence to Susan W. Denfield, MD, Division of Pediatric Cardiology, Texas Children’s Hospital, 6621 Fannin, MC 2-2280, Houston, TX 77030. E-mail srivenes{at}bcm.tmc.edu
Background—Restrictive cardiomyopathy (RCM) is rare in children, and the prognosis is poor. In the present study, we evaluated all pediatric patients with RCM who were at our institution during a 31-year period to determine the clinical outcome and cause of death. Those who sustained sudden, unanticipated cardiac arrests were evaluated for risk factors that are predictive of sudden death.
Methods and Results—Eighteen consecutive patients were reviewed. Presentation, clinical course, laboratory data, and histopathological evidence of ischemia were compared between patients with and without sudden death events. The results demonstrated that patients who were at risk for sudden death were girls with chest pain, syncope, or both at presentation and without congestive heart failure. Although not statistically significant for sudden death, Holter monitor evidence of ischemia predicted death within months. Histopathological evidence of acute or chronic ischemia was found in the majority of patients, with acute ischemia more common among those who sustained sudden death events.
Conclusions—All children with RCM are at risk for ischemia-related complications and death, and some are at risk of sudden death. In the present study, patients at risk of sudden death appeared well and had no evidence of ongoing heart failure but often had signs or symptoms of ischemia characterized by chest pain, syncope, or both. ECGs and Holter monitors may be useful screening tools. The use of ß-blockade, the placement of an implantable cardioverter-defibrillator, and preferential status 1A or B listing for cardiac transplantation are proposed for pediatric patients with RCM and evidence of ongoing ischemia.
Key Words: pediatrics • cardiomyopathy • death, sudden • ischemia • syncope
This article has been cited by other articles:
 |
|
 |
|
  J. Du, J. Liu, H.-Z. Feng, M. M. Hossain, N. Gobara, C. Zhang, Y. Li, P.-Y. Jean-Charles, J.-P. Jin, and X.-P. Huang Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2604 - H2613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Pinto, M. S. Parvatiyar, M. A. Jones, J. Liang, and J. D. Potter A Troponin T Mutation That Causes Infantile Restrictive Cardiomyopathy Increases Ca2+ Sensitivity of Force Development and Impairs the Inhibitory Properties of Troponin J. Biol. Chem., January 25, 2008; 283(4): 2156 - 2166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Zemljic-Harpf, J. C. Miller, S. A. Henderson, A. T. Wright, A. M. Manso, L. Elsherif, N. D. Dalton, A. K. Thor, G. A. Perkins, A. D. McCulloch, et al. Cardiac-Myocyte-Specific Excision of the Vinculin Gene Disrupts Cellular Junctions, Causing Sudden Death or Dilated Cardiomyopathy Mol. Cell. Biol., November 1, 2007; 27(21): 7522 - 7537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, J. Du, C. Zhang, J. W. Walker, and X. Huang Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1273 - H1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Davis, H. Wen, T. Edwards, and J. M. Metzger Thin Filament Disinhibition by Restrictive Cardiomyopathy Mutant R193H Troponin I Induces Ca2+-Independent Mechanical Tone and Acute Myocyte Remodeling Circ. Res., May 25, 2007; 100(10): 1494 - 1502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, February 6, 2007; 115(5): 658 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Peddy, L. A. Vricella, J. E. Crosson, G. L. Oswald, R. D. Cohn, D. E. Cameron, D. Valle, and B. L. Loeys Infantile Restrictive Cardiomyopathy Resulting From a Mutation in the Cardiac Troponin T Gene Pediatrics, May 1, 2006; 117(5): 1830 - 1833. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Gomes, J. Liang, and J. D. Potter Mutations in Human Cardiac Troponin I That Are Associated with Restrictive Cardiomyopathy Affect Basal ATPase Activity and the Calcium Sensitivity of Force Development J. Biol. Chem., September 2, 2005; 280(35): 30909 - 30915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L M Russo and S A Webber Idiopathic restrictive cardiomyopathy in children Heart, September 1, 2005; 91(9): 1199 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Nugent, P. E.F. Daubeney, P. Chondros, J. B. Carlin, M. Cheung, L. C. Wilkinson, A. M. Davis, S. G. Kahler, C.W. Chow, J. L. Wilkinson, et al. The Epidemiology of Childhood Cardiomyopathy in Australia N. Engl. J. Med., April 24, 2003; 348(17): 1639 - 1646. [Abstract] [Full Text] [PDF]
|
|